Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice

Renal fibrosis is considered to be the final common outcome of chronic kidney disease. Dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated protective effects against diabetic kidney disease. However, the anti-fibrotic effect of evogliptin, a DPP-4 inhibitor, has not been studied. Here, we re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Metab J
Autors principals: Kim, Mi-Jin, Kim, Na-young, Jung, Yun-A, Lee, Seunghyeong, Jung, Gwon-Soo, Kim, Jung-Guk, Lee, In-Kyu, Lee, Sungwoo, Choi, Yeon-Kyung, Park, Keun-Gyu
Format: Artigo
Idioma:Inglês
Publicat: Korean Diabetes Association 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043988/
https://ncbi.nlm.nih.gov/pubmed/31701692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0271
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars